MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CRSP has $2,265,243K in assets. $343,430K in debts. $347,559K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1331.59%
Quick Ratio
1331.59%
Cash Ratio
233.07%
Debt to Asset Ratio
15.16%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities, net...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
347,559
Marketable securities
1,628,269
Accounts receivable
0
Prepaid expenses and other current assets
9,843
Total current assets
1,985,671
Total property and equipment, gross
206,903
Accumulated depreciation
91,052
Property and equipment, net
115,851
Restricted cash
7,629
Operating lease assets
131,724
Other non-current assets
24,368
Total assets
2,265,243
Accounts payable
11,138
Accrued expenses
89,407
Deferred revenue, current
15,771
Accrued tax liabilities
1,113
Operating lease liabilities
18,578
Other current liabilities
13,113
Total current liabilities
149,120
Deferred revenue, non-current
0
Operating lease liabilities, net of current portion
188,168
Other non-current liabilities
6,142
Total liabilities
343,430
Common shares, chf 0.03 nominal value, 132,477,166 shares authorized at december 31, 2025 and december 31, 2024, 96,009,657 and 85,912,297 shares issued at december 31, 2025 and december 31, 2024, respectively, 95,894,341 and 85,741,981 shares outstanding at december 31, 2025 and december 31, 2024, respectively
3,087
Treasury shares, at cost, 115,316 and 170,316 shares at december 31, 2025 and december 31, 2024, respectively
60
Additional paid-in capital
3,861,516
Accumulated deficit
-1,947,551
Accumulated other comprehensive income
4,821
Total shareholders equity
1,921,813
Total liabilities and shareholders equity
2,265,243
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$1,628,269K Cash and cashequivalents$347,559K Prepaid expenses andother current assets$9,843K Total property andequipment, gross$206,903K Total current assets$1,985,671K Operating lease assets$131,724K Property and equipment,net$115,851K Other non-currentassets$24,368K Restricted cash$7,629K Accumulated depreciation$91,052K Total assets$2,265,243K Total liabilities andshareholders equity$2,265,243K Total shareholdersequity$1,921,813K Total liabilities$343,430K Accumulated deficit-$1,947,551K Treasury shares, at cost,115,316 and 170,316...$60K Additional paid-in capital$3,861,516K Operating leaseliabilities, net of current...$188,168K Total currentliabilities$149,120K Other non-currentliabilities$6,142K Accumulated othercomprehensive income$4,821K Common shares, chf 0.03nominal value,...$3,087K Accrued expenses$89,407K Operating leaseliabilities$18,578K Deferred revenue,current$15,771K Other currentliabilities$13,113K Accounts payable$11,138K Accrued tax liabilities$1,113K

CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG (CRSP)